P&G Beauty teardown: $15B segment, 18% net margin, and what the gorilla's profit pressure teaches indie skincare DTC operators

P&G Beauty did $14.96 billion in net sales in FY25, the year to 30 June 2025. That is down 2 percent year on year. Segment net earnings were $2.72 billion, down 8 percent. The net-earnings margin fell 140 basis points to 18.1 percent, the second straight year of margin compression from a 21.2 percent peak in FY23. For a $5-50M DTC skincare operator, the read is sharper than the headline. P&G discloses that its Beauty segment runs the highest gross margin in the company portfolio (above the 51.2 percent corporate average) and that Beauty GM compressed another 130 bps in FY25. That puts the implied Beauty GM band at roughly 55 to 60 percent, which is the same band most indie skincare DTC brands operate in. You cannot out-cost P&G. The differentiation has to live somewhere else. This piece walks the FY25 numbers, the Skin Care distribution-loss story (Olay sits inside it), the FY26 sales bounce that did not save margin, and what the gorilla's profit pressure teaches a brand at one-thousandth its size.

The number P&G won't print, and why it matters

P&G's reportable segments are Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care. Each one gets a disclosed net sales line, a disclosed net earnings line, and commentary in the MD&A. None of them gets a disclosed segment gross margin. That is a US GAAP choice (segment disclosures follow what the chief operating decision maker uses internally) and the CODM at P&G uses earnings-before-tax and net earnings, not GM.

What you do get for Beauty is two anchors. First, P&G's consolidated gross margin in FY25 was 51.2 percent, down 20 bps from FY24. Second, the FY25 10-K MD&A states explicitly that the Beauty segment has higher gross margins than the company average, and that Beauty GM declined 130 basis points in FY25 (attributed to unfavorable product mix from the SK-II super-premium decline and higher commodities, partially offset by productivity savings).

Work back from those two anchors and one more. Beauty's segment net-earnings margin is 18.1 percent on $14.96B of net sales, which translates to about $2.72B of net earnings. P&G's consolidated effective tax rate in FY25 was 22.5 percent, which back-implies a Beauty pre-tax operating contribution of roughly $3.5B, or about 23 percent of segment net sales. Now overlay the MD&A statement that Beauty sits above the 51.2 percent company GM and dropped 130 bps in FY25 (which puts FY24 above where FY25 landed). The arithmetic that reconciles all three anchors lands the FY25 Beauty GM in the 55 to 60 percent band, with segment SG&A and advertising eating roughly 32 to 37 percent of net sales. That GM band is the same range most $5-50M DTC skincare brands operate in. Below 55 percent, you are giving back too much in promo and influencer comp. Above 60 percent, you are usually running owned brand with vertical manufacturing or a price point above $60 average order value. P&G's 55-60 percent is what a global, vertically-integrated, 5-percent-share business gets after a century of supply-chain optimization. Treat it as your floor, not your ceiling.

The bar chart above also says something most operators miss. Beauty is not even P&G's highest-margin segment. Grooming (Gillette, Venus) runs a 23.7 percent net-earnings margin on the back of 45-percent-plus global share in razors. Fabric & Home Care runs 22.0 percent. Beauty's 18.1 percent is the lowest of the five despite carrying the highest gross margin. That gap is what advertising spend looks like when you have to keep buying share against indie disruptors.

What broke in FY25: Skin Care distribution, SK-II, and the tariff drip

P&G's FY25 Beauty disclosure breaks the segment into four sub-categories: Hair Care, Personal Care, Skin Care (Olay, SK-II), and Personal Cleansing. The split came into force on 1 July 2024 and is the first time investors get to see Skin Care on its own line.

What that disclosure revealed was ugly, and the two primary sources tell slightly different stories. The FY25 10-K MD&A says Skin Care net sales fell high-single-digits in FY25, with Hair Care net sales down low-single-digits (organic up low-single-digits) and Personal Care net sales up high-single-digits (organic also up high-single-digits). P&G's FY25 Q4 earnings release, by contrast, says Skin Care organic sales were unchanged for the year, with volume growth in Greater China offset by volume decline in North America and unfavorable mix. The reconciling factor is the gap between reported net sales (10-K) and organic sales (earnings release): unfavorable FX, mix, and the SK-II super-premium decline pull reported into negative territory while organic flatlines. Either way, the North America volume story is the operator-relevant part. The Personal Care strength was hiding the Skin Care weakness for at least two years before the segment split forced the truth into the open.

The MD&A attributes the Skin Care decline to two distinct dynamics. SK-II, the super-premium brand sold predominantly into Greater China, was hit by consumer downtrading away from the very top of the price ladder. Olay, the mass-skincare brand sold predominantly into North America, was hit by what P&G calls distribution losses. In plain language, the gorilla is losing shelf to mid-mass indie brands at retail and to indie DTC brands online. The 10-K does not name names, and we will not either. The pattern from industry observation is that the shelf vacated by Olay since FY24 has been refilled by a mix of mid-mass dermatology brands (mostly held by other public conglomerates) and indie skincare DTC at the teen through millennial price points. The specific share-shift quantification is not in the public filings.

Period	Net sales ($M)	YoY %	Net earnings ($M)	Net earnings margin %	Notes
FY23	15,008	n/d	3,178	21.2%	Baseline pre-segment-reorg
FY24	15,220	+1%	2,963	19.5%	SK-II decline starts; -170 bps
FY25	14,964	-2%	2,715	18.1%	Skin Care -HSD net sales (organic flat); -140 bps; -130 bps GM
Q1 FY26 (Jul-Sep 2025)	4,142	+3%	773	18.7%	Modest recovery; FX tailwind starts
Q2 FY26 (Oct-Dec 2025)	4,040	+2%	750	18.6%	Net earnings flat to modest
Q3 FY26 (Jan-Mar 2026)	3,866	+11%	579	15.0%	Sales bounce on FX and volume (price only +1pt); GM -210 bps
9M FY26 (Jul25-Mar26)	12,048	+7%	2,102	17.4%	Margin still below FY25 full year

The tariff drip is the third weight on Beauty margin. P&G disclosed 10 basis points of consolidated tariff drag in the FY25 10-K. The Q3 FY26 10-Q calls out higher tariff costs as part of the 210 bps GM decline that quarter. The Beauty-specific exposure is not separately disclosed. For an indie DTC brand sourcing from Korea, Japan or China, the same drag applies on a smaller absolute base. The operator question is whether you have priced for it or absorbed it.

The skincare CPI window: when the macro stops cooperating

P&G's pricing contribution to Beauty net sales growth was +4 percentage points in FY24 and +2 percentage points in FY25. That fall happened inside a window when category-level CPI for cosmetics, perfume, bath and nail preparations deflated.

The FRED series CUUR0000SEGB02 peaked at +5.7 percent year on year in January 2023, drifted down through 2024, hit a trough of -1.0 percent in March 2025, and has since climbed back to +2.8 percent in April 2026. P&G's pricing contribution maps directly to that arc. When the macro CPI is positive, P&G can put 4 points of price into Beauty without volume dropping. When the macro is flat or negative, the same brand can only put 2 points through.

The operator point is structural. Your category-level CPI is the upper bound on your annual price increases. If your brand sits in cosmetics, perfume, bath or nail (the CUUR0000SEGB02 basket), the macro window is now open: +2.8 percent year on year and trending up. If you have not raised price in 18 months, you are leaving 200 to 300 basis points on the table. P&G is using that window mostly for volume and FX recapture rather than price (the Q3 FY26 +11 percent net sales bounce was +5 points volume, +4 points FX, +1 point price, +1 point mix). For a smaller brand without those volume tailwinds, price is the lever you actually have.

This is the same dynamic we saw in the average DTC return rate by vertical analysis, where category-level macro variables (return rates, CAC, conversion) set the floor and individual brand discipline determines how far below or above that floor you land.

Why this matters for a $5-50M DTC beauty brand

Translate the P&G Beauty file into operator decisions and you get four moves.

First, your gross margin band is the gorilla's gross margin band. P&G Beauty's implied 55 to 60 percent GM is what a global vertically-integrated mass-skincare business gets after a century of cost engineering. If your blended GM is in the same band, you cannot out-cost the gorilla. The differentiation has to come from brand (a price-elastic story consumers will pay for), product velocity (frequency and assortment depth, not bigger basket), or channel mix (DTC with retention software, not paid acquisition into a one-shot funnel). Eliminating cost as a competitive moat is the most useful thing P&G's GM disclosure tells you.

Second, distribution losses are happening at real shelves. P&G says Skin Care had a volume decline in North America in FY25 and characterizes it as distribution loss. If you are winning shelf in CVS, Walgreens, Target or Ulta right now, you are stealing it from Olay (and from a long tail of mid-mass legacy brands). Indie skincare DTC that is now also at retail is doing the same. The window is open right now precisely because the gorilla is flinching. The window will close when P&G's productivity savings program recaptures enough margin to fund the marketing push to take shelf back. Use the window.

Third, when the category CPI flips positive, your pricing window opens too. April 2026's +2.8 percent CPI YoY for cosmetics is the macro signal. P&G is using it for volume. You can use it for price. In the brands we operate with, a 3 to 4 percent price increase across the hero SKU set, taken in the next 90 days, tends to land at the top end of what the macro allows without spiking return rate. Skip the window and you are funding next year's growth out of margin instead of out of price.

Fourth, the net-earnings margin benchmark is 18 percent at the gorilla's scale, and yours can be higher. P&G Beauty's 18.1 percent net-earnings margin is what you get after the segment's full advertising and SG&A load spread across $15B of revenue. In the brands we work with, a well-run $20M DTC skincare operator running paid plus organic at sensible levels with a tight team can clear 18 percent on a net basis, and the better ones clear 25 percent. The gorilla's margin is your floor, not your aspiration. If you are running below 18 percent at $20M revenue, the question is what you are spending money on that P&G is not.

For the related read on what 5-50M DTC beauty brand unit economics look like in practice, see our average ecommerce CAC by vertical and average gross margin by CPG category pieces.

What to watch in FY26 H2 and FY27

Three signals on the dashboard.

First, Beauty global market share. The Q3 FY26 10-Q says Beauty global market share is still down 0.3 points YTD FY26. If that does not stabilize by the FY26 full-year print (August 2026), the Olay North America narrative gets worse and the productivity-savings program has to do more to fund the marketing push. If it stabilizes, P&G is starting to defend.

Second, Skin Care volume in North America. FY25 saw a North America volume decline that P&G attributes to distribution loss. Q3 FY26 commentary suggests sequential improvement but the NA print is still soft. A return to flat or positive NA Skin Care volume would mean indie share gains are slowing, which would tighten the window for new entrants. A second year of NA volume decline would mean the window stays wide open.

Third, Beauty gross margin trajectory. Q3 FY26 was -210 bps. FY25 full year was -130 bps. The trend is the wrong direction. If FY26 full-year Beauty GM compresses another 150 to 200 bps the structural pressure is accelerating, which usually triggers either a price reset (good for indie pricing power) or a marketing pullback (good for indie share gains). Watch both.

Even a $15B Beauty business at 51 percent corporate GM cannot out-cost an indie brand at the same gross margin level. The gorilla's cost advantage stopped scaling somewhere around FY22, which is exactly when indie skincare DTC started taking shelf in North America. If you are operating between $5 million and $50 million in beauty right now, the macro window is open, your competitor's pricing is flat, and your gross margin is structurally inside P&G's band. Treat your next 12 months as a window, not a steady state.

Sources and methodology

This teardown draws on three primary SEC filings, one FRED time series, and a triangulation read from earnings-call summaries.

The P&G Form 10-K for fiscal year 2025 (accession 0000080424-25-000076, filed 4 August 2025) is the source for Beauty segment FY25 and FY24 net sales, net earnings, organic sales, the four-sub-category split (Hair Care, Personal Care, Skin Care, Personal Cleansing), and the explicit MD&A commentary on Beauty gross margin movement (-130 basis points), tariff drag (10 bps consolidated), and the company's productivity-savings program. The 10-K MD&A's statement that Beauty has higher gross margins than the company average is the single most useful disclosure for any operator trying to triangulate the absolute level.

The P&G Form 10-Q for Q3 FY2026 (accession 0000080424-26-000060, filed 24 April 2026) is the source for Q3 FY26 Beauty net sales ($3,866M, +11 percent), net earnings ($579M), and the 210 bps Q3 GM decline attribution. Nine-month FY26 Beauty net sales of $12,048M and net earnings of $2,102M come from the same 10-Q. Q1 and Q2 FY26 figures come from prior 10-Qs cross-referenced in the year-to-date table.

The P&G Form 10-K for fiscal year 2024 (accession 0000080424-24-000083, filed 5 August 2024) provides the comparative baseline for FY24 Beauty net sales ($15,220M) and net earnings ($2,963M) and the restated FY23 figures ($15,008M / $3,178M) that appear in the FY25 10-K.

The FRED CUUR0000SEGB02 time series (CPI Cosmetics, Perfume, Bath, Nail Preparations and Implements, NSA monthly index 1982-1984=100) was pulled at year-on-year percent change for calendar 2020 through April 2026. Fiscal-year averages aggregate monthly observations across each P&G fiscal year (1 July to 30 June). This is the closest BLS series to a clean skincare-only category and bundles cosmetics, perfume, bath and nail under one index. Directionally right for indie beauty operators, not perfect.

Limitations. P&G does not disclose an absolute Beauty segment gross margin in either the 10-K or 10-Q. The 55-60 percent band cited in this piece is a derived estimate from (a) the 51.2 percent company average, (b) the MD&A statement that Beauty is above average, (c) the 18.1 percent Beauty net-earnings margin, and (d) the -130 bps FY25 Beauty GM change. Treat it as triangulated, not disclosed. The two P&G primary sources disagree on Skin Care's FY25 direction: the FY25 10-K MD&A reports Skin Care net sales -high-single-digits, while the FY25 Q4 earnings release reports Skin Care organic sales unchanged ("volume growth in Greater China was offset by a volume decline in North America and unfavorable mix"). The gap is reported-versus-organic plus mix and FX. We have cited both. Olay-specific net sales and margin are also not disclosed; only Skin Care sub-segment commentary is available, and Skin Care includes both Olay and SK-II. The Chart 2 comparison of segment net-earnings margins uses Grooming, Beauty and Health Care figures from direct 10-K disclosure; the Fabric & Home Care and Baby/Feminine/Family Care figures are derived from segment net earnings and net sales reconciliations and should be treated as approximate. The Estée Lauder 71-74 percent gross margin range cited in one FAQ is from EL's most recent 10-K and is for reference only, not a primary source for this teardown. Indie beauty share gains in North America are stated as qualitative narrative in the 10-K; specific Nielsen or Circana share-shift data is not in the public source set and is not cited here. Currency: USD. Accounting standard: US GAAP. P&G's fiscal year ends 30 June.

Frequently asked questions

what gross margin does p&g actually run in its beauty segment?

P&G does not publish an absolute Beauty segment gross margin in either the 10-K or 10-Q. What it does say in the FY25 MD&A is that Beauty has higher gross margins than the company average (which is 51.2%) and that Beauty GM fell 130 basis points year on year. Anchoring against the 18.1% segment net-earnings margin, the -130 bps Beauty GM move, and the MD&A "above average" language, the implied band lands in the 55 to 60 percent zone. Treat that as a derived estimate, not a disclosed number.

why doesn't p&g disclose the exact gross margin for beauty?

Segment GM is not required by US GAAP. The chief operating decision maker at P&G uses earnings-before-tax and net earnings to assess each segment, not gross margin. That means segment GM stays in management's hands, not investors'. It is a defensible disclosure choice, and it is also why anyone benchmarking against P&G has to work back from net-earnings margin and the MD&A narrative.

is olay losing share to indie beauty brands?

Yes, in North America specifically. The FY25 10-K MD&A says Skin Care had volume declines and unfavorable mix in North America, driven by what P&G characterizes as distribution losses. The 10-K does not name names, but Olay is the dominant US mass skincare brand in the segment, so the share that is moving is moving from Olay to mid-mass indie brands at retail and to DTC indie brands online. SK-II's super-premium decline is a separate story driven by Greater China consumer downtrading.

what's a realistic gross margin target for a $10m skincare dtc brand?

55 to 70 percent at the blended level is the band most $5-50M DTC skincare brands we work with land inside. If you are below 55 percent your promo and influencer comp is probably eating margin you should be keeping. Above 70 percent usually means owned brand with vertical manufacturing or a price-point above $60 AOV with low return rate. P&G Beauty's likely 55-60 percent is your floor, not your ceiling.

how does p&g beauty's 18% net earnings margin compare to indie beauty p&l?

P&G Beauty's 18.1 percent segment net-earnings margin is what you get after the segment's full advertising and SG&A load is spread across $15B of revenue. A well-run $20M DTC skincare brand can run a higher net margin than that because it does not carry the same overhead. The right framing is: 18 percent is the gorilla's floor, not its ceiling, and your indie unit economics can beat it on a percentage basis at much smaller scale.

why did p&g split skin care and personal care into separate segments in 2024?

Effective 1 July 2024 P&G reorganized the Beauty segment so investors could see Skin Care (Olay, SK-II) on its own line instead of bundled with Personal Care (Old Spice, Secret). The first thing that disclosure revealed was that Skin Care net sales fell high-single-digits in FY25 while Personal Care grew high-single-digits. Bundling had been masking the skincare weakness for at least two years. For an operator, the lesson is that the way you cut your own KPI deck can hide trouble too.

should i benchmark my dtc beauty brand against p&g or against estée lauder?

Both, but for different things. P&G Beauty is the benchmark for mass-skincare unit economics and what a structurally healthy CPG operator looks like when its category goes flat. Estée Lauder is the benchmark for prestige-skincare unit economics and what happens when a premium-positioned business gets caught in the same Greater China downtrading cycle. EL's gross margin sits in the 71-74 percent range, P&G Beauty's implied is 55-60 percent, and your blended target lives somewhere in between depending on price point and channel mix.

how should i think about pricing power when the category cpi is flat or deflating?

Treat CPI for your category as the upper bound on your price increases for the next 12 months. When CPI for cosmetics, perfume, bath and nail preparations deflated through FY25, P&G could only push 2 points of price into Beauty net sales (down from 4 points in FY24). If you are a small DTC brand the same constraint applies. When category CPI flips positive again your window opens. The April 2026 CPI print for that basket was +2.8 percent YoY, which is exactly when P&G Beauty's top line bounced. Watch the macro signal before you set next year's price book.